INTRODUCTION
Human T-cell leukaemia virus type I (HTLV-I) is a retrovirus causally associated with adult T-cell leukaemia-lymphoma (ATLL) (Gallo, 1984; Weiss, 1985) . HTLV-I can transform human T-cells in vitro to a state of indefinite proliferation (immortal growth) (Miyoshi et al., 1981 ; Popovic et al., 1983) . The virus naturally infects human T-lymphocytes with the mature T4 cell phenotype, but productive infection of HTLV-I has also been observed in human B-cell lines (Gallo, 1984; Okada et al., 1984) and simian, rabbit and rat T-lymphoid lines have been transformed in vitro Tateno et al., 1984; Weiss, 1985) .
Non-lymphoid cells of different species also express cell surface receptors for HTLV-I and HTLV-II Weiss et al., 1985) and fibroblastic, epithelial and endothelial cells of human and feline origin have been productively infected Hoshino et al., 1983 ; Ho et al., 1984; Hoxie et al., 1984) . Infection of a human osteogenic sarcoma cell line (HOS) resulted in a virus-producing, non-lymphoid cell subline, HOS/PL . The ultrastructure of HTLV-I-transformed human lymphoma cells has been examined previously (Catovsky et al., 1984) . Using immunoelectron microscopy with sera from ATLL patients, binding of antibody to HTLV-I-producing cells and to the envelope of virus particles was seen (Nakai et al., 1982; Ohtsuki et al., 1983) as well as to cells infected with simian T-cell leukaemia virus (Haga et al., 1986) . Using a monoclonal antibody (MAb), the presence of an antigen related to pl 9 core protein of HTLV-I was demonstrated on the infected cell surface and the envelope of virions (Aoki et al., 1984) .
The aim of this study was to investigate by immunoelectron microscopy the virus-cell interactions and the expression of HTLV-I envelope and core antigens in HOS/PL cells compared to a HTLV-I-producing human T-lymphoid cell line, C91/PL. We have also observed the presence of major histocompatibility complex (HLA class 1)-associated protein, human betaz-microglobulin, in the envelope of HTLV-I virions derived from lymphoid and nonlymphoid cells. By contrast, human HLA class 1 antigen is absent from virions but present on HOS/PL cells.
METHODS

Cells.
The HTLV-I-producing human T-lymphoid cells C91/PL were maintained in RPMI 1640 medium supplemented with 10 ~ heat-inactivated foetal calf serum. The human osteosarcoma cell line (HOS) and HOS/PL (an HTLV-I-producing derivative) were grown as monolayers and were used at confluence . Syncytium assays for HTLV-I production using HOS cells were performed as described previously .
Electron microscopy. For ultrastructural studies the cells were fixed in 1 ~ glutaraldehyde (GA; Emscope Laboratories, Ashford, U.K.) buffered with 0"08M-sodium cacodylate pH 7.2 or in 1~ GA in complete phosphate-buffered saline (PBS) for 1 h, washed in appropriate buffer and were then post-fixed in 1 ~ OsO4 (Emscope) buffered with cacodylate for 1 h at room temperature. After 30 min washing in distilled water, the cells were dehydrated in a graded series of alcohol and were embedded into Araldite (Emscope). In the case of monolayers, the cells were fixed and processed in situ on plastic culture wells and were floated off using propylene oxide. Ultrathin sections were made on a Reichert Ultrotome using a diamond knife and were contrasted with lead citrate or with uranyl acetate followed by lead citrate. The electron micrographs were taken on a Phillips EM-300 microscope at an accelerating voltage of 80 kV.
HTL V-I antibody binding assay. The cells were labelled at 4 °C for 30 min before fixation or after 10 min fixation in 0.5~ GA/PBS and multiple washing in PBS at room temperature. Two anti-HTLV-I sera were used, one moderate titre serum from an ATLL patient and one high titre from an asymptomatic subject (neutralization titres of 1 : 6250 and 1 : 31250 respectively); these were assayed by immunofluorescence and by neutralization (Clapham et al., 1984) . Anti-HTLV-I was diluted 1 : 100 in PBS. After adsorption to cells and multiple washing in PBS, an unlabelled bridging antibody (mouse monoclonal anti-human IgG; Miles Laboratories), diluted 1 : 200 in PBS was added to the cells at 4 °C or at room temperature for 30 rain. After further PBS washes, anti-mouse IgG conjugated with 5 nm colloidal gold (GAMG5; Janssen Pharmaceutica, Beerse, Belgium) diluted 1 : 10 in PBS was layered on the cells for another 30min at 4 °C or at room temperature. The colloidal gold served as an electron-dense marker. The immunocytochemical controls were uninfected cells and HTLV-I-producing cells labelled with an incomplete sequence of label by omitting primary or secondary antibodies. The controls showed no labelling with colloidal gold. After the last series of PBS washings, the cells were post-fixed with GA and OsO4 and processed as described above.
HTLV-I p19 detection Surface labelling. Cells were pre-fixed as described above, washed in PBS and labelled at 1 : 50 dilution in PBS for 30 rain at room temperature with anti-HTLV-I p19 mouse MAb (Robert-Guroffet al., 1981) . After multiple washings in PBS the cells were stained with GAMG5 at 1 : 10 dilution in PBS for 30min and processed as above.
Intracellular labelling. The cells were pre-fixed, washed in PBS and permeabilized in 0.2~ Triton-X in PBS for 5rain at room temperature, thoroughly washed in PBS and labelled with the GAMG5 for 1 h periods. Immunocytochemical controls were an inappropriate mouse MAb [vesicular stomatitis virus (VSV) anti-N protein] labelling on HTLV-l-infected cells, omission of primary antisera or use of uninfected cells in a complete series of p 19 labelling. The cells were then processed for electron microscopy as for surface labelling. The controls showed a rare occurrence of single gold particles in the cytoplasm.
Human beta2-microglobulin detection. Cells were stained by post-fixation labelling with anti-human beta 2-microglobulin polyclonal IgG (affinity-purified rabbit IgG, Miles Laboratories) at 1:20 dilution in PBS for 30 min at room temperature, washed in PBS and labelled with goat anti-rabbit [gG-ferritin conjugate (Miles Laboratories) at 1 : 20 dilution in PBS for another 30 min. The use of inappropriate first antibody (anti-ricin rabbit IgG) or the omission of first antibody served as controls and showed no ferritin labelling.
FIB-75 MAb detection of HLA class I antigens. Cells were labelled after post-fixation with purified LON-LICR FIB-75 mouse MAb (Edwards et al., 1980) at 1:50 dilution in PBS for 30 min. After thorough washing in PBS, GAMG5 at 1 : 10 dilution was applied in PBS for 30min. The use of inappropriate primary antibody (anti-mouse H2 MAb) or the omission of first antibody served as controls and showed no binding of the gold.
RNA staining. RNA staining was done on ultrathin sections of GA-fixed material according to Bernard (1969) , using EDTA and uranyl acetate followed by lead citrate. Fig. 1 shows the typical morphological features of C91/PL cells. These cells are of variable size with indented or convoluted nuclei. Ceils of two other HTLV-I-transformed lines, C 10/M J2 and HUT102, were morphologically very similar to C91/PL. In the extracellular space and on the cell surface, retrovirus particles were abundant. The virions were typical of the HTLV/bovine leukaemia virus group (Fig. 2 ) with variable diameters ranging from 80 to 150 nm. Besides mature virions with large nucleoids, empty vesicles with similar diameters also frequently occurred. Budding virions were a very rare feature in the C91/PL cell line. In the cytoplasm, the dominant structures were the Golgi and the lysosomal systems. Vesicles containing viral particles were observed (Fig. 3) near multivesicular bodies or lysosomes. A rare observation was the occurrence of tubuloreticular structures (TRS) (Fig. 4) which are inclusion bodies in the endoplasmic reticulum (ER). The nuclei frequently contained complex nuclear bodies.
RESULTS
HTL V-I-producing human T-lymphoid cells
The majority of virus particles bound immunogold label after surface labelling with human anti-HTLV-I, but the tracer appeared to bind only to small sectors of the virion surface and particularly to material external to the virions (Fig, 5a) . HTLV-I membrane antigen was also present on small regions of the plasma membrane of C91/PL cells (Fig. 5b) . The occurrence of HTLV-I p 19 antigen was a rare feature on the surface of these cells in small discrete areas (Fig. 6a ), but much more label was associated with the extracellular material (Fig. 6a, b ) and very sparse labelling was found on some mature virions (Fig. 6b) . The controls did not show the presence of any tracer immunogold particles at all (Fig. 6c) .
HTL V-I-producing non-lymphoid cells
Co-cultivation for 24 h of C91/PL T-cells with HOS fibroblastic cells resulted in frequent syncytium formation (Fig. 7a) among the HOS cells as described by Nagy et al. (1983) . HTLV-I particles did not occur at the plasma membrane of these cells. In the HOS/PL cell line persistently infected with HTLV-I, multinucleated cells (Fig. 7 b) occurred more rarely, although such cells induced abundant syncytia when mixed with uninfected HOS cells (Weiss et al., 1985) . The syncytia had a predominant rough ER system and vast numbers of microvilli. The HOS/PL cells were morphologically similar to non-infected HOS cells and the flattened cells formed multilayers. Virions with diameters of 80 to 150 nm were observed more frequently in the intercellular spaces than on free surfaces (Fig. 8a, b) . A moderate amount of ER and Golgi apparatus were present but the dominant cytoplasmic organelles were free ribosomes. Nucleic acid-staining of cells with uranyl acetate revealed RNA in the core of the viral particles (Fig.  9a) . Material exterior to the virion envelope was labelled with ATLL patient's serum (Fig. 9b) . After permeabilization of membranes, extraceUular virions were heavily labelled with HTLV-I p19 monoclonal antibody (Fig. 9c) .
Budding virions were more frequently seen on HOS/PL cells (Fig. 10a ) than on C91/PL cells. With uranyl acetate staining, the subplasmalemmal areas resembling budding virions were strongly and relatively homogeneously stained for RNA (Fig. 10b) . The ATLL patient's serum also bound to putative budding areas (Fig. 10c) . Virions were frequently observed in coated pits (Fig. 10a and lla) . Sometimes the RNA staining revealed budding virions close to early endocytosis on a neighbouring cell (Fig. 11 b) .
Particles were found both in coated (Fig. 11 c) and in uncoated (Fig. 11 d) cytoplasmic vesicles. Complete particles were also frequently found in multi-vesicular bodies (Fig. 12a ). These were presumably transferred to phagolysosomes, in which both complete virions and de-enveloped ones occurred in abundance (Fig. 12b) , and contained RNA (Fig. 12c) . In the ER, TRS were apparent (Fig. 13a) as in C91/PL cells but these were not seen in uninfected HOS cells. Alteration of the nuclear membrane (CIII-type; Schaff et al., 1984) was also observed (Fig. 13 b) and within the nuclei, complex nuclear bodies were frequently seen.
The surfaces of HOS/PL cells expressed patches of HTLV-I membrane antigen (Fig. 14a, b) . Nearly all the cells were positive for antigen, consistent with previous immunofluorescence studies . HTLV-I membrane antigen was evenly distributed on free J, TIMAR AND OTHERS 1014 6 ( b )
," " intercellular and basal plasma membranes. In contrast to uninfected HOS cells (Fig. 15b) , HTLV-I p 19 core antigen was present diffusely in the cytosol of HOS/PL cells, and in some areas clustering of antigen was found (Fig. 15a) . Human beta2-microglobulin was detected by ferritin-labelled antibody on the surface of C91/PL cells (Fig. 16a) and HOS/PL cells (not shown). This antigen was also regularly seen on HTLV-I particles of C91/PL cells (Fig. 16a) and on HOS/PL cells (Fig. 16b) , localized above small sectors of the HTLV-I envelope resembling the anti-HTLV labelling (Fig. 5a, 9b) . The material bridging the particles and the cell surface was also labelled (Fig. 16 c) . However, FIB-75
MAb reacting with an epitope common to human HLA class 1-related antigens (Edwards et al., 1980; Buckman et al., 1982) was not bound to the HTLV-I virion envelopes produced by C91/PL cells (Fig. 17a) or HOS cells (Fig. 17b) . HLA class 1 antigen was not present on the membrane of lymphoid C91/PL cells (Fig. 17a) but was expressed on the fibroblastic HOS and HOS/PL cells (Fig. 17b) . It would appear that the major polypeptide of HLA class 1 antigen is not incorporated into the envelope of HTLV-I and therefore the beta2-microglobulin may be binding directly to a viral antigen.
DISCUSSION
Although sharing the common feature of HTLV-I production, the ultrastructure of the HOS/PL human osteosarcoma cell line was entirely different from the C91/PL lymphoid line. However, both the infected cell lines but not uninfected HOS cells contained inclusion bodies in the ER (Fig. 4 and 13a ) known as undulating membranous structures or TRS (Schaffet al., 1972 (Schaffet al., , 1984 . TRS have been observed in T-lymphoid cells after treatment with interferon (Grimley et al., 1983) , and are also a characteristic feature in lymphocytes of patients with acquired immune deficiency syndrome and Kaposi's sarcoma (Gyorkey et al., 1982; Grimley et al., 1984) .
Although TRS appear in various types of virus-infected cell and tumour cell, they are not known to contain viral structural elements (Schaff et al., 1976) . HTLV-I-producing T-lymphoid cells produce different types of lymphokine including 7-interferon (Salahuddin et al., 1984) , and the appearance of TRS in these cells might be related to interferon induction rather than the virus production. Fig. 3 . Cytoplasmic part of a C91/PL cell. In the vicinity of a multivesicular body and Golgi system there is an intracytoplasmic vesicle containing a HTLV-I particle (arrow). GA and OsO4 fixation, lead counterstain. Bar marker represents 150 nm 
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Different stages in virus-cell interaction were easily detectable in HOS/PL cells from budding, free virions and early steps of infection. The virus was taken up by the cells via endocytosis and coated vesicles to the intracellular acidic compartment, comprising the endosomes, multivesicular bodies and lysosomes. Some degree of uncoating occurred in the lysosomes resulting in the appearance of RNA-containing lysosomes. In contrast, the occurrence of intracellular HTLV-I particles was rarely observed in T-lymphoid cells. These data provide evidence that HTLV-I is taken up by the cells via receptor-mediated endocytosis and the virion core is transferred to the cytoplasm from the acidic cytoplasmic vesicle compartment, as described for other enveloped viruses (Helenius et al., 1980; Mathis et al., 1981 ; Nemerov & Cooper, 1984) . Fully productive HOS/PL ceils, however, exhibit interference with syncytium induction and the plating of pseudotypes, presumably because the receptors are saturated (Weiss et al., 1985) . HOS and HOS/PL cells do not express T-lymphocyte surface markers and it is evident that cellular receptors for HTLV-I are not restricted to lymphoid cells (Hoshino et al., 1983; N agy et al., 1983 ; Clapham et al., 1984; Weiss et al., 1985) .
HTLV-I membrane antigens are widely distributed on the surface of infected lymphoid and non-lymphoid cells. The antigenic sites occurred in small, well defined patches of membrane, similar in size to the labelled sectors of the HTLV-I envelope. In our experiments, using a 1 : 100 dilution of an ATLL patient's serum, the localization of membrane antigen in the HTLV envelope was more precise than was previously demonstrated at higher concentrations of ATLL patients' sera (Nakai et al., 1982; Ohtsuki et al., 1983) . The envelope of HTLV-I particles was not labelled evenly, even when serum containing a high titre of neutralizing antibody (Clapham et al., 1984) was used for indirect immunogold labelling. Further investigation of the distribution of the HTLV-I env gene products, p21E and gp46, on virion envelopes will be needed using MAbs to these antigens.
The presence of HTLV-I p19 core protein was demonstrated with MAb as being localized diffusely in the cytosol of HOS/PL cells, occasionally forming clusters. The appearance of p 19 on the free surfaces and in the extracellular spaces supports the previous observations (Aoki et al., 1984) that this core antigen, or possibly a p28 molecule containing p19 epitopes (Tanaka et al., 1983) becomes exposed on the cell and virion surface, like the envelope antigen. Both the lymphoid and non-lymphoid cells producing HTLV-I expressed human betaz-microglobulin on the surface of cells and virions. Beta2-microglobulin associates specifically with HLA class 1 antigens. However, we observed no labelling of HTLV-I virions using a MAb reacting to a constant region of HLA antigen. In this context it is noteworthy that HTLV-I-transformed lymphocytes exhibit altered specificity of HLA antigen expression and that 
